tradingkey.logo

Exact Sciences Announces Medicare Coverage For Oncodetect™ Molecular Residual Disease

ReutersJul 9, 2025 10:01 AM

- Exact Sciences Corp EXAS.O:

  • EXACT SCIENCES ANNOUNCES MEDICARE COVERAGE FOR ONCODETECT™ MOLECULAR RESIDUAL DISEASE TEST IN COLORECTAL CANCER

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI